Mathiowetz Alan M
Pfizer Worldwide Research and Development, Cambridge, MA, USA.
Methods Mol Biol. 2019;2001:1-15. doi: 10.1007/978-1-4939-9504-2_1.
One of the most exciting facets of cyclic peptides is that they have the potential to be orally bioavailable, despite having physical properties well beyond the traditional "Rule-of-5" chemistry space (Lipinski et al., Adv Drug Deliv Rev. 23(1): 3-25, 1997). An important component of meeting this challenge is to design cyclic peptides with good intestinal permeability. Here we discuss the design principles for intestinal permeability that have been developed in recent year. These principles can be subdivided into three regimes: physical property guidelines, design strategies for the macrocyclic ring, and design strategies for side chains. The most important overall aims are to minimize solvent-exposed polarity while keeping size, flexibility, and lipophilicity within favorable ranges, thereby allowing peptide chemists to achieve intestinal permeability in addition to other important properties for their compounds, such as solubility and binding affinity. Here we describe a variety of design strategies that have been developed to help peptide chemists in this endeavor.
环肽最令人兴奋的一个方面是,尽管它们的物理性质远远超出了传统的“五规则”化学空间(Lipinski等人,《药物递送进展综述》,1997年,第23卷第1期,第3 - 25页),但它们仍有可能具有口服生物利用度。应对这一挑战的一个重要组成部分是设计具有良好肠道通透性的环肽。在此,我们讨论近年来开发的肠道通透性设计原则。这些原则可细分为三个方面:物理性质指导原则、大环的设计策略以及侧链的设计策略。最重要的总体目标是在保持大小、柔韧性和亲脂性在合适范围内的同时,尽量减少溶剂暴露的极性,从而使肽化学家除了实现化合物的其他重要性质(如溶解度和结合亲和力)之外,还能实现肠道通透性。在此,我们描述了为帮助肽化学家实现这一目标而开发的各种设计策略。